Anjali Singh

Mahindra's XEV 9S, XUV 7XO clock nearly 94,000 bookings on launch day

Mahindra's newly launched XEV 9S and XUV 7XO SUVs drew strong initial demand, with nearly 94,000 bookings on the first day, translating into orders worth over Rs 20,500 crore

IPA members commit $50 million to set up pharma skilling academy PAGE

IPA member firms have committed $50 million to launch PAGE, an industry-led academy to boost pharmaceutical manufacturing skills, quality systems and regulatory compliance in India

Two-wheeler industry expects 6-9% growth in 2026 on GST cut, urban demand

India's two-wheeler industry is seen growing 6-9% in 2026, though a proposed ABS mandate for sub-125cc models could push up prices and temper volumes

2-wheeler industry eyes 6-9% growth in 2026 on GST-led affordability boost

India's two-wheeler industry is expected to grow 6-9% in 2026, aided by the GST cut, improved affordability and steady rural and urban demand, analysts said

India's diagnostics pivots to precision tests as high-value segments grow

Industry leaders say demand for these higher-value tests aimed at early disease detection, personalised treatment and long-term health management has been expanding far faster than routine pathology

SUV demand holds steady in used market despite GST-led price cuts

Despite GST relief making small cars cheaper, India's used-car market continues to favour SUVs, which are seeing faster inventory turnover and stronger residual values, industry executives say

Supriya Life Sciences bets on regulated markets with new facility

The Mumbai-based pharma company has commissioned a ₹165-crore formulations plant at Ambernath to support contract manufacturing and strengthen its presence in regulated global markets

Carmakers flex dealer, service networks to drive growth beyond metros

Network scale seen as central to tapping smaller markets

Mahindra bets on AI and skills to drive its 'Tech-First' transformation

Chairman Anand Mahindra says artificial intelligence, skills and education reforms will reshape work, talent flows and growth, as the Group sharpens its technology-focused strategy

Indian pharma companies see sharp drop in adverse USFDA findings in 2025

OAI cases nearly halve in 2025, overall inspection volumes also fell 25%

Ducati bets on India-EU FTA as 40% GST weighs on luxury motorcycles

Ducati India says the 40 per cent GST on large-capacity bikes has added pressure on demand and is counting on the proposed India-EU FTA to ease import costs from 2026

Hyundai India enters commercial mobility segment amid rising competition

Hyundai Motor India has launched Prime HB and Prime SD taxi models with petrol and CNG options, aiming to diversify volumes as domestic competition heats up and rankings tighten

Lupin signs exclusive India pact with Gan & Lee for fortnightly GLP-1 drug

Lupin has signed an exclusive licensing, supply and distribution deal with China's Gan & Lee for Bofanglutide, a fortnightly GLP-1 injectable for diabetes and weight management in India

Preventive, precision testing spurs a bigger dose of diagnostics chains

Diagnostic chains are expanding laboratories, integrated centres and collection networks as demand grows for preventive, genomics-led and precision testing across India

Triumph, Renault to raise vehicle prices from Jan 2026 amid cost pressures

Triumph will revise ex-showroom prices across its range from January 1, while Renault India will raise prices by up to 2 per cent, urging buyers to lock in current rates

Precision oncology gains ground as India clears targeted cancer therapies

A string of CDSCO approvals and reviews is accelerating India's move to immunotherapies, ADCs and targeted drugs, widening options in major cancers and boosting competition

India's diagnostics market shifts to preventive, precision testing in 2025

India's diagnostics sector is seeing a strong shift towards preventive and precision-led testing in 2025, driven by rising demand for proactive health checks and faster genomic diagnostics

Tata Motors' EV arm to launch five new models by FY30; capex Rs 18,000 cr

Tata Passenger Electric Mobility plans five new EV models by FY30 and Rs 16,000-18,000 crore capex on products, technology and charging infrastructure as Tata EV sales cross 250,000 units

HN Reliance Foundation Hospital launches tele-robotic surgery programme

HN Reliance Foundation Hospital has launched a tele-robotic surgery programme, allowing Mumbai surgeons to remotely perform, guide robotic procedures at a Jamnagar partner centre using Jio's network

Emcure targets pan-India obesity market with Poviztra semaglutide

As GLP-1 competition heats up, Emcure is pricing semaglutide brand Poviztra at ₹8,790 a month and targeting demand beyond metros with deeper distribution in smaller cities